Before the advent of NGS, patients who underwent germ-line genetic testing for hereditary cancer were typically tested for a limited number of genes that were strongly associated with a single hereditary cancer syndrome, such as BRCA1/2 or the Lynch genes. The gene discussed is BRCA1; the disease is Inherited cancer-predisposing syndrome.